Literature DB >> 2758555

UKCCCR guidelines for the welfare of animals in experimental neoplasia.

.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2758555     DOI： 10.1007/BF00047059

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN： 0167-7659            Impact factor:   9.264


× No keyword cloud information.
  3 in total

1.  Quantitation of tumour response: a critical appraisal. Proceedings of the 9th L. H. Gray Conference held at St Catharine's College, Cambridge 11-14 September 1979.

Authors: 
Journal:  Br J Cancer Suppl       Date:  1980-04

2.  The use of rodent tumors in experimental cancer therapy. Conclusions and recommendations from an international workshop.

Authors:  R F Kallman; J M Brown; J Denekamp; R P Hill; J Kummermehr
Journal:  Cancer Res       Date:  1985-12       Impact factor: 12.701

3.  Role of murine tumor models in cancer treatment research.

Authors:  D S Martin; M E Balis; B Fisher; E Frei; E J Freireich; G H Heppner; J F Holland; J A Houghton; P J Houghton; R K Johnson
Journal:  Cancer Res       Date:  1986-04       Impact factor: 12.701
  3 in total
  7 in total

Review 1.  Technical considerations for studying cancer metastasis in vivo.

Authors:  D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

2.  Impact of taurolidin and octreotide on liver metastasis and lipid peroxidation after laparoscopy in chemical induced ductal pancreatic cancer.

Authors:  Maik Kilian; Jan Ilga Gregor; Ina Heukamp; Chris Braumann; Hans Guski; Ingolf Schimke; Martin Karl Walz; Christoph Andreas Jacobi; Frank Axel Wenger
Journal:  Invest New Drugs       Date:  2005-03       Impact factor: 3.850

3.  MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis.

Authors:  Ulrike Stein; Wolfgang Walther; Franziska Arlt; Holger Schwabe; Janice Smith; Iduna Fichtner; Walter Birchmeier; Peter M Schlag
Journal:  Nat Med       Date:  2008-12-21       Impact factor: 53.440

4.  The prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancer.

Authors:  Alessandra Rustighi; Luca Tiberi; Alessia Soldano; Marco Napoli; Paolo Nuciforo; Antonio Rosato; Fred Kaplan; Anthony Capobianco; Salvatore Pece; Pier Paolo Di Fiore; Giannino Del Sal
Journal:  Nat Cell Biol       Date:  2009-01-18       Impact factor: 28.824

5.  Impact of Octreotide and SOM-230 on liver metastasis and hepatic lipidperoxidation in ductal pancreatic adenocarcinoma in Syrian Hamster.

Authors:  M Kilian; J I Gregor; I Heukamp; K Helmecke; M Hanel; B Wassersleben; M K Walz; I Schimke; G Kristiansen; F A Wenger
Journal:  Clin Exp Metastasis       Date:  2009-06-12       Impact factor: 5.150

6.  Antibody-antigen-adjuvant conjugates enable co-delivery of antigen and adjuvant to dendritic cells in cis but only have partial targeting specificity.

Authors:  Martin Kreutz; Benoit Giquel; Qin Hu; Ram Abuknesha; Satoshi Uematsu; Shizuo Akira; Frank O Nestle; Sandra S Diebold
Journal:  PLoS One       Date:  2012-07-10       Impact factor: 3.240

7.  Apelin Controls Angiogenesis-Dependent Glioblastoma Growth.

Authors:  Anne Frisch; Stefanie Kälin; Raymond Monk; Josefine Radke; Frank L Heppner; Roland E Kälin
Journal:  Int J Mol Sci       Date:  2020-06-11       Impact factor: 5.923
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.